Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 25, 2024
Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting SystemEmanuela Elisa Sorbara, Maria Antonietta Barbieri, Giulia Russo, et al.
Pharmaceutics|March 19, 2020
Cannabinoids, Blood-Brain Barrier, and Brain DispositionFabrizio Calapai, Luigi Cardia, Emanuela Elisa Sorbara, et al.
Phytotherapy Research : PTR|March 16, 2021
A standardized extract of Opuntia ficus-indica (L.) Mill and Olea europaea L. improves gastrointestinal discomfort: A double-blinded randomized-controlled studyGiuseppe Antonio Malfa, Claudia Di Giacomo, Luigi Cardia, et al.
Frontiers in Pharmacology|March 14, 2022
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance DatabaseMaria Antonietta Barbieri, Emanuela Elisa Sorbara, Alessandro Battaglia, et al.
Drugs - Real World Outcomes|September 16, 2021
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance DatabaseMaria Antonietta Barbieri, Emanuela Elisa Sorbara, Giuseppe Cicala, et al.
Medicine|October 21, 2020
Clinical use of omega-3 fatty acids in migraine: A narrative reviewLuigi Cardia, Fabrizio Calapai, Cristina Mondello, et al.
Cancers|March 29, 2023
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting SystemMaria Antonietta Barbieri, Emanuela Elisa Sorbara, Giulia Russo, et al.
BMC Pediatrics|January 12, 2021
Efficacy and safety of the syrup "KalobaTUSS®" as a treatment for cough in children: a randomized, double blind, placebo-controlled clinical trialIlaria Carnevali, Rita La Paglia, Lara Pauletto, et al.
Biomedicines|August 26, 2023
Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System DatabaseGiulia Russo, Maria Antonietta Barbieri, Emanuela Elisa Sorbara, et al.
Antioxidants (Basel, Switzerland)|February 11, 2021
Nutraceuticals against Oxidative Stress in Autoimmune DisordersCarmen Mannucci, Marco Casciaro, Emanuela Elisa Sorbara, et al.
Pageof 2